 treatment advanced-stag hodgkin diseas altern noncrossresist mopp/cab superior mopp twenty-f assess patient advanced-stag hodgkin diseas mechlorethamin vincristin procarbazin prednison mopp mopp lomustin ccnu bleomycin streptozocin cab median follow-up year complet respons rate mopp-treat patient mopp/cabs-tr patient differ signific level disease-fre surviv curv follow-up mopp-treat patient mopp/cabs-tr patient differ signific overal surviv year mopp-treat patient mopp/cabs-tr patient differ signific signific differ efficaci mopp mopp/cab mopp/cab emetogen mopp mopp/cabs-tr patient secondari acut leukemia mopp-treat patient leukemia high initi erythrocyt sediment rate esr high platelet count treatment outcom mopp-treat patient dose intens vincristin first cycl disease-fre surviv rate mopp/cabs-tr patient dose intens vincristin overal surviv disease-fre surviv arm patient dose intens agent effect dose intens appar patient poor prognost factor dose intens agent disease-fre overal surviv